Previous 10 | Next 10 |
Ahead of its annual investor conference scheduled for today, Edwards Lifesciences (EW +1.7%) has reaffirmed its previously issued financial guidance for 2021. The health care equipment maker also announced its 2022 financial guidance indicating $5.5 - $6.0 billion in global sales for the year...
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference PR Newswire IRVINE, Calif. , Dec. 8, 2021 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) will discuss the company's strategy for longer-term growth, provide an update on its ...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Wells Fargo has upgraded Edwards Lifesciences (NYSE:EW) to overweight citing growth in transcatheter aortic valve replacements (TAVRs). The firm has a $126 price target (~13% upside). Analyst Larry Biegelsen expects pivotal trial data that will be presented next year on the Pascal transc...
Credit Suisse drops its best of the best picks to seven stocks for December. Credit Suisse Product Manager Andrew St. Pierre defines the "Top of the Crop" stocks as the "highest conviction combined with the least demanding market expectations. And four new names make that list. The "Top of th...
My new portfolio has already seen most companies release earnings, and results look promising. Therefore, I will cover the first thirteen companies in this article, and then the last twelve after all reports have been filed. I will be quite brief with my summaries, but I will cove...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Edwards Announces Six-month Data From Transcatheter Tricuspid Replacement Program PR Newswire IRVINE, Calif. , Nov. 6, 2021 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced that results from a clinical trial of the company's EVOQUE trans...
TAVR with SAPIEN 3 Demonstrated as Economically Dominant Treatment Strategy Compared to Surgery in Partner 3 Analysis PR Newswire IRVINE, Calif. , Nov. 5, 2021 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced that a cost-effectiveness analysis...
I've had some good discussions about my policy of selling high-quality stocks if they have become extremely overvalued. Many investors prefer to hold the stocks of quality businesses that have performed well regardless of the valuation. In this article, I share data on 43 of the h...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - July 30, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to provide this update in regard to the status of the proposed return of capital announced on June 19, 2024 . The Company has prepared and mailed its ...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 1.7% to $112.28 on volume of 455,296,152 shares Ford Motor Company (F) fell 18.4% to $11.16 on volume of 256,384,806 shares PROSHARES TRUST (SQQQ) rose 3.4% to $9.37 on volume of 246,885,889 shares Sel...
2024-07-25 16:00:08 ET Pito Chickering from Deutsche Bank issued a price target of $85.00 for EW on 2024-07-25 13:36:00. The adjusted price target was set to $85.00. At the time of the announcement, EW was trading at $60.58. The overall price target consensus is at $109....